Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Serdar İleri
Observed names:
S Ileri,
S İleri,
S. Ileri,
S. İleri,
Serdar Ileri,
Serdar İLERİ
show all 6
Institution:
Diyarbakır Gazi Yaşargil Eğitim ve Araştırma Hastanesi
Observed institutions:
Dicle University,
Adıyaman University,
Sağlık Bilimleri Üniversitesi,
Diyarbakır Gazi Yaşargil Eğitim ve Araştırma Hastanesi,
Sanofi (Turkey),
Adıyaman Eğitim ve Araştırma Hastanesi,
Harran University
show all 7
ORCID:
0000-0002-3739-3528
Observed ORCID:
0000-0002-3739-3528
OpenAlex ID:
A5082156791
Malignant melanoma of the stomach presenting in a woman: a case report
2011
·
Vedat Goral
, Feyzullah Ucmak
, et al.
·
Journal of Medical Case Reports
·
33
PDF
Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
2025
·
Yasin Sezgin
, Oğur Karhan
, et al.
·
Scientific Reports
·
9
PDF
Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study
2025
·
Ogur Karhan
, Serdar İleri
, et al.
·
Therapeutic Advances in Medical Oncology
·
5
Predictive value of the FIB-4 index, APRI, ALBI score, and GPR for overall survival in treatment-naïve metastatic colorectal cancer patients
2025
·
Mehmet Serdar Yıldırım
, Yunus Güzel
, et al.
·
BMC Gastroenterology
·
5
PDF
Predicting pathologic complete response in triple negative breast cancer
2024
·
Oğur Karhan
, Erkan Bilen
, et al.
·
Eastern Journal Of Medicine
·
4
PDF
Should new organ involvement be included in Response Evaluation Criteria in PSMA Imaging?
2024
·
İhsan Kaplan
, Halil Kömek
, et al.
·
Annals of Nuclear Medicine
·
3
Mesenteric Panniculitis as a Side Effect of Nivolumab in a Patient with Larnyngeal Cancer
2024
·
O Karhan
, Y Sezgin
, et al.
·
Nigerian Journal of Clinical Practice
·
3
Are Syrian refugee breast cancer patients diagnosed at advanced stage and do they have treatment delays?
2023
·
Ogur Karhan
, Saban Secmeler¹
, et al.
·
Future Oncology
·
3
PDF
Concomitant Use of Proton Pump Inhibitors and CDK4/6 Inhibitors in Metastatic Hormone-Positive Breast Cancer: A Real-World Cohort Study
2024
·
Ogur Karhan
, Serdar İleri
, et al.
·
Oncology
·
2
Assessing the Efficacy and Safety of Shorter versus Extended Adjuvant Treatment Duration for Stage III Low-Risk Colon Cancer: A Comparative Analysis
2025
·
NO Kalkan
, G Ucar
, et al.
·
Nigerian Journal of Clinical Practice
·
1
Real-life Data of Pazopanib Usage in Soft Tissue Sarcoma
2023
·
Oğur KARHAN
, Serdar İLERİ
, et al.
·
Turkish Journal of Clinics and Laboratory
·
1
PDF
Pretreatment prognostic nutritional index is associated with survival outcomes in locally advanced NSCLC treated with definitive chemoradiotherapy
2026
·
Serdar İleri
, Sezai Tunç
, et al.
·
Scientific Reports
PDF
Correction: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
2026
·
Yasin Sezgin
, Oğur Karhan
, et al.
·
Scientific Reports
PDF
142P Evaluation of clinicopathological features and prognoses of Ewing sarcoma patients over 65 years of age
2026
·
I. Dogan
, O. Karhan
, et al.
·
ESMO rare cancers.
PDF
80MO Evaluation of clinicopathological features and prognoses of patients with brain sarcoma
2026
·
H. Yerlikaya
, O. Karhan
, et al.
·
ESMO rare cancers.
PDF
145P Evaluation of clinicopathological features and prognoses of patients with cardiac sarcoma
2026
·
I. Dogan
, S. Ileri
, et al.
·
ESMO rare cancers.
PDF
149P Evaluation of clinicopathological features and prognoses of adult patients with rhabdomyosarcoma
2026
·
H. Yerlikaya
, S. Ileri
, et al.
·
ESMO rare cancers.
Prognostic Impact of FLT3, NPM1 and CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia
2026
·
Serdar İleri
, Orhan Ayyıldız
·
Eurasian Journal of Medical Advances
PDF
HPR236 Assessing the Reimbursement Landscape of Oncology Products in the Turkish Pharmaceutical Market
2024
·
M Kurnaz
, B Tibet
, et al.
·
Value in Health
HPR193 Evaluation of the Reimbursement Status and Market Access of Oncology Medicines in Türkiye: A Descriptive Analysis
2024
·
S Okcun
, G Kockaya
, et al.
·
Value in Health
PDF
HPR247 Analysis of Oncology Medicine Distribution in Türkiye: A Focus on Indication, Molecule, and Generic Status
2024
·
S Okcun
, O Seyhun
, et al.
·
Value in Health
The relationship between coronary and cardiac computed tomography measurements and sarcopenia in older adults
2024
·
S. İleri
, M. Pehlivan
, et al.
·
Clinical Nutrition ESPEN
Comparison of First-Line Chemotherapeutics and Validation of the EORTC Prognostic Index in Malignant Pleural Mesothelioma: Retrospective Single-Centre Experience
2024
·
Yasin Sezgin
, Ogur Karhan
, et al.
·
Journal of College of Physicians And Surgeons Pakistan
Effect of Maintenance anti-EGFR Therapy on Survival in Metastatic RAS Wild-Type Colorectal Cancer: Single-Center Experience
2024
·
Serdar Ileri
·
Eurasian Journal of Medical Investigation
Survival outcomes of patients diagnosed with muscle-invasive bladder cancer who showed a response after neoadjuvant chemotherapy and refused radical cystectomy, and patients who had radical cystectomy or received chemoradiotherapy
2023
·
Sezai Tunç
, Zuhat Urakçı
, et al.
·
Oncology in Clinical Practice
PDF
Show more works
View as search
Works count:
30
Citation count:
69
H-index:
4
I10-index:
1
Year
Topic
Type